Active Immunization
Also known as: Active immunisation / Immunization, Active / Prophylactic vaccination / Vaccination / Administration of vaccine to produce active immunity (procedure) / Response to active immunization (finding) / Vaccination booster dose / Immunisation / Immunisations / Immunization / Administration to produce immunity, either active or passive (procedure)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB16726 | Influenza A virus A/Tasmania/503/2020 (H3N2) antigen (MDCK cell derived, propiolactone inactivated) | In combination with other influenza virus subtypes A and types B strains, this Influenza A viral strain is used for active immunization of adults and children aged 6 months or... |
| DB15857 | Janssen COVID-19 Vaccine | An adenovirus-based vaccine used for active immunization against COVID-19 caused by SARS-CoV-2 infection. |
| DB17762 | Respiratory syncytial virus vaccine, adjuvanted | An adjuvanted respiratory syncytial virus vaccine in older adults. |
| DB10317 | Rubella virus vaccine | A vaccine used to prevent Rubella. |
| DB13932 | Voretigene neparvovec | An adeno-associated viral gene therapy used to treat biallelic RPE65 mutation associated retinal dystrophy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB13932 | Voretigene neparvovec | Retinoid isomerohydrolase | target |
| Drug | Drug Name | Phase | Status | Count |
|---|